Lifevantage PE Ratio 2010-2024 | LFVN

Current and historical p/e ratio for Lifevantage (LFVN) from 2010 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Lifevantage PE ratio as of November 07, 2024 is 23.23.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

Lifevantage PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2024-11-06 13.94 77.44
2024-09-30 12.08 $0.18 67.11
2024-06-30 6.39 $0.23 27.78
2024-03-31 5.99 $0.28 21.39
2023-12-31 5.91 $0.23 25.70
2023-09-30 6.32 $0.20 31.59
2023-06-30 4.00 $0.20 20.00
2023-03-31 3.28 $-0.06 0.00
2022-12-31 3.37 $-0.05 0.00
2022-09-30 3.37 $0.04 84.24
2022-06-30 3.88 $0.24 16.16
2022-03-31 4.21 $0.70 6.02
2021-12-31 5.59 $0.73 7.66
2021-09-30 5.99 $0.98 6.11
2021-06-30 6.51 $0.90 7.23
2021-03-31 8.28 $0.81 10.22
2020-12-31 8.25 $0.80 10.31
2020-09-30 10.68 $0.84 12.72
2020-06-30 11.97 $0.79 15.15
2020-03-31 9.12 $0.79 11.54
2019-12-31 13.82 $0.80 17.27
2019-09-30 12.13 $0.56 21.66
2019-06-30 11.49 $0.50 22.98
2019-03-31 12.65 $0.45 28.11
2018-12-31 11.68 $0.45 25.95
2018-09-30 9.73 $0.41 23.73
2018-06-30 5.64 $0.41 13.75
2018-03-31 3.20 $0.21 15.22
2017-12-31 4.21 $0.09 46.82
2017-09-30 3.74 $0.09 41.50
2017-06-30 3.83 $0.11 34.84
2017-03-31 4.75 $0.26 18.28
2016-12-31 7.21 $0.33 21.86
2016-09-30 8.37 $0.42 19.94
2016-06-30 12.04 $0.42 28.66
2016-03-31 8.06 $0.26 30.98
2015-12-31 8.43 $0.26 32.41
2015-09-30 5.02 $0.22 22.81
2015-06-30 3.28 $0.49 6.70
2015-03-31 4.90 $0.63 7.77
2014-12-31 8.06 $0.70 11.51
2014-09-30 7.06 $0.84 8.41
2014-06-30 8.92 $0.70 12.75
2014-03-31 8.12 $0.56 14.50
2013-12-31 10.22 $0.63 16.24
2013-09-30 14.75 $0.42 35.13
2013-06-30 14.38 $0.42 34.24
2013-03-31 14.56 $0.70 20.81
2012-12-31 13.57 $0.14 96.93
2012-09-30 21.25 $0.49 43.38
2012-06-30 17.54 $0.42 41.75
2012-03-31 23.30 $-3.78 0.00
2011-12-31 8.86 $-4.34 0.00
2011-09-30 9.29 $-4.27 0.00
2011-06-30 9.29 $-4.34 0.00
2011-03-31 4.40 $-0.98 0.00
2010-12-31 2.42 $-1.05 0.00
2010-09-30 3.10 $-1.54 0.00
2010-06-30 3.16 $-1.47 0.00
2010-03-31 2.42 $-1.75 0.00
2009-12-31 1.55 $-1.54 0.00
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $0.175B $0.200B
Lifevantage Corporation is a health and nutrition company. The company is the maker of Protandim(R), the Nrf2 Synergizer(R) patented dietary supplement, the TrueScience(TM) Anti-Aging Skin Care Regimen, Canine Health and the AXIO(TM) energy product line. Lifevantage Corporation is headquartered in Salt Lake City, Utah.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $71.233B 19.03
Becton Dickinson (BDX) United States $69.388B 18.80
Cardinal Health (CAH) United States $27.972B 15.17
West Pharmaceutical Services (WST) United States $23.854B 48.72
Cooper (COO) United States $20.668B 29.42
Labcorp (LH) United States $19.603B 16.25
Align Technology (ALGN) United States $16.786B 32.12
Henry Schein (HSIC) United States $8.871B 16.63
Merit Medical Systems (MMSI) United States $5.972B 30.50
DENTSPLY SIRONA (XRAY) United States $4.861B 13.03
CONMED (CNMD) United States $2.337B 19.50
Patterson (PDCO) United States $1.938B 10.23
STAAR Surgical (STAA) United States $1.521B 56.11
Pro-Dex (PDEX) United States $0.140B 27.95